Latest News by Industry
BRISBANE, Calif. (AP) — BRISBANE, Calif. (AP) — CareDx Inc. (CDNA) on Wednesday reported a loss of $23.5 million in its third quarter.
The Brisbane, California-based company said it had a loss of 43 cents per share. Losses, adjusted for stock option expense and non-recurring costs, were 18 cents per share.
The molecular diagnostics company posted revenue of $67.2 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $53.7 million.
CareDx expects full-year revenue in the range of $274 million to $278 million.
CareDx shares have decreased 45% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $6.33, a decline of 61% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CDNA at https://www.zacks.com/ap/CDNA